Without Clinical Oversight GLP-1 medications carry real risks that HumeCare's own safety materials disclose in detail - a boxed warning regarding thyroid tumors, contraindications for certain personal and family medical histories, and interactions with other medications including insulin, sulfonylureas, and oral contraceptives
For example, semaglutide is composed of 31 amino acids (Figure 1), and tirzepatide is even larger with 39 amino acid residues
Tirzepatide
This is allowed because it's not available commercially
Renal impairment pharmacists should check individual drug SPC for recommendations as dose adjustments may be required and can vary between individual drugs
The Bottom Line (Plain English) Weeks 12: appetite changes, little scale movement Weeks 36: weight loss often begins Months 36: meaningful, sustained loss for many Semaglutide: slower start, steady progress Tirzepatide: faster early loss for some, same long-term rules apply GLP-1 rewards patience not urgency